drugset / Trial / NCT00314964

Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause

NCT00314964 ↗

Phase 2 Completed 527 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study is to determine if PD-0299685 is effective and safe in the treatment of vasomotor symptoms (hot flashes / flushes) associated with menopause.

Timeline

Start
2006-08
Primary completion
—
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject PD 0299685 Small molecule — —

Indications

No indication recorded.